A Clinical Study of BioTTT001 in Combination With SOX and Toripalimab in Patients With Peritoneal Metastases From Gastric Cancer
Conditions: Gastric Cancer, Metastatic Interventions: Biological: BioTTT001 intraperitoneal infusion; Drug: SOX regimen; Drug: toripalimab Sponsors: China Medical University, China; Beijing Bio-Targeting Therapeutics Technology Co., Ltd Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | China Health | Gastric (Stomach) Cancer | Gastroenterology | Peritoneal Cancer | Research | Study